Mp49-16 Factors Predicting Failure to Follow Pre-Scheduled Gemcitabine Plus Cisplatin Chemotherapy Regimen for Urothelial Carcinoma
Journal of Urology - Netherlands
doi 10.1016/j.juro.2016.02.429
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)